Singh K, Orr J M, Abbott F S
CIBA-GEIGY Corporation, Summit, NJ 07901.
J Pharmacobiodyn. 1990 Oct;13(10):622-7. doi: 10.1248/bpb1978.13.622.
A pharmacologically active monounsaturated metabolite of valproic acid (VPA), (E)-2-ene VPA, was administered by an intravenous bolus dose of 20 mg/kg to normal and bile-exteriorized rats. The total plasma clearance of (E)-2-ene VPA in normal rats was 4.9 ml/min/kg and in bile-exteriorized rats, 7.7 ml/min/kg. (E)-2-ene was recycled in the plasma of normal rats due to enterohepatic circulation. Approximately 32% of the dose was excreted in the urine of normal rats. Of the administered dose to bile exteriorized rats, approximately 27% was excreted in the urine and 38% in the bile. Administration of (E)-2-ene increased bile flow rate, and the induced choleresis lasted for 3-4 h. (E)-2-ene VPA was largely excreted in apparently conjugated form in the urine and bile. The pharmacokinetics of (E)-2-ene VPA were similar to that of the parent drug VPA.
将丙戊酸(VPA)的一种具有药理活性的单不饱和代谢物(E)-2-烯丙戊酸以20毫克/千克的静脉推注剂量给予正常大鼠和胆汁外引流大鼠。正常大鼠中(E)-2-烯丙戊酸的总血浆清除率为4.9毫升/分钟/千克,胆汁外引流大鼠中为7.7毫升/分钟/千克。由于肝肠循环,(E)-2-烯在正常大鼠血浆中被再循环。约32%的剂量在正常大鼠尿液中排泄。给予胆汁外引流大鼠的剂量中,约27%在尿液中排泄,38%在胆汁中排泄。给予(E)-2-烯可增加胆汁流速,诱导的胆汁分泌持续3至4小时。(E)-2-烯丙戊酸在尿液和胆汁中主要以明显结合的形式排泄。(E)-2-烯丙戊酸的药代动力学与母体药物VPA相似。